This drives the recruitment of CD8 + T cells to the tumor and reverses ICB resistance.516 Follow-up studies have shown that CBL0137 can also induce Z-DNA-mediated necroptotic cell death in liver cancer, demonstrating the potential of CBL0137 as a cancer therapeutic agent.517. Here, CD8A is linked to neoplasm.